In Brief: Rhone-Poulenc Rorer
Rhone-Poulenc Rorer: Sodium ferric gluconate complex injection is marketed in some European countries by RPR. Makoff R&D Labs has distribution and trademark rights to the product Ferrlecit in the U.S., U.K., Canada and a number of other countries. Schein has sub-distribution rights from Makoff for the product in the U.S. ("The Pink Sheet" March 9, p. 7)...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth